BTR Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$525K Buy
7,469
+15
+0.2% +$1.18K 0.08% 109
2022
Q2
$597K Hold
7,454
0.09% 104
2022
Q1
$565K Hold
7,454
0.07% 115
2021
Q4
$636K Hold
7,454
0.07% 111
2021
Q3
$563K Hold
7,454
0.07% 113
2021
Q2
$606K Sell
7,454
-75
-1% -$6.13K 0.08% 110
2021
Q1
$594K Sell
7,529
-200
-3% -$15.7K 0.09% 104
2020
Q4
$661K Buy
7,729
+30
+0.4% +$2.48K 0.1% 98
2020
Q3
$594K Sell
7,699
-100
-1% -$7.63K 0.11% 95
2020
Q2
$571K Buy
7,799
+700
+10% +$49.7K 0.11% 98
2020
Q1
$471K Sell
7,099
-935
-12% -$65.9K 0.1% 102
2019
Q4
$553K Sell
8,034
-53
-0.7% -$3.61K 0.1% 105
2019
Q3
$594K Sell
8,087
-39
-0.5% -$2.83K 0.11% 100
2019
Q2
$582K Sell
8,126
-28
-0.3% -$1.99K 0.11% 102
2019
Q1
$559K Buy
8,154
+53
+0.7% +$3.42K 0.11% 104
2018
Q4
$482K Hold
8,101
0.1% 109
2018
Q3
$542K Buy
8,101
+2,135
+36% +$142K 0.09% 108
2018
Q2
$387K Hold
5,966
0.07% 102
2018
Q1
$428K Sell
5,966
-400
-6% -$28.8K 0.09% 100
2017
Q4
$480K Hold
6,366
0.09% 99
2017
Q3
$464K Hold
6,366
0.09% 102
2017
Q2
$472K Hold
6,366
0.1% 105
2017
Q1
$466K Sell
6,366
-2,361
-27% -$165K 0.1% 105
2016
Q4
$647K Hold
8,727
0.15% 94
2016
Q3
$647K Hold
8,727
0.15% 94
2016
Q2
$639K Sell
8,727
-50
-0.6% -$3.56K 0.15% 100
2016
Q1
$620K Sell
8,777
-575
-6% -$38.3K 0.14% 101
2015
Q4
$623K Buy
9,352
+50
+0.5% +$3.33K 0.14% 110
2015
Q3
$590K Buy
9,302
+1,600
+21% +$105K 0.14% 108
2015
Q2
$504K Sell
7,702
-172
-2% -$11.7K 0.12% 103
2015
Q1
$546K Sell
7,874
-50
-0.6% -$3.46K 0.13% 100
2014
Q4
$548K Sell
7,924
-800
-9% -$54K 0.15% 88
2014
Q3
$569K Sell
8,724
-100
-1% -$6.6K 0.16% 83
2014
Q2
$602K Hold
8,824
0.17% 86
2014
Q1
$572K Sell
8,824
-200
-2% -$12.6K 0.17% 88
2013
Q4
$588K Hold
9,024
0.17% 90
2013
Q3
$535K Sell
9,024
-600
-6% -$35.5K 0.17% 91
2013
Q2
$551K Buy
+9,624
New +$571K 0.17% 91

Other funds holding CL

BTR Capital Management's CL Position: Q3 2022 in Review

BTR Capital Management increased its Colgate-Palmolive (CL) stake by 0.2% in Q3 2022, buying an estimated $1.18K and bringing the position to 7,469 shares worth $525K. The position accounts for 0.08% of the portfolio, ranked #109.

BTR Capital Management first reported a position in CL in Q2 2013 and has held it in 38 quarters since. The position peaked at $661K in Q4 2020. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.

  • BTR Capital Management held 7,469 shares of Colgate-Palmolive worth $525K as of Q3 2022.
  • BTR Capital Management bought 15 Colgate-Palmolive shares in Q3 2022, an estimated $1.18K.
  • Colgate-Palmolive made up 0.08% of BTR Capital Management's portfolio in Q3 2022, its #109 holding.
  • BTR Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 38 quarters since.
  • BTR Capital Management's Colgate-Palmolive position peaked at $661K in Q4 2020.
  • 1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on BTR Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.